Hamlet BioPharma AB Statistics
Total Valuation
XSAT:HAMLET.B has a market cap or net worth of SEK 1.13 billion. The enterprise value is 1.13 billion.
Important Dates
The next confirmed earnings date is Thursday, February 11, 2027.
| Earnings Date | Feb 11, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
XSAT:HAMLET.B has 186.18 million shares outstanding.
| Current Share Class | 146.27M |
| Shares Outstanding | 186.18M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 25.95% |
| Owned by Institutions (%) | 8.47% |
| Float | 97.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 697,031.23 |
| PB Ratio | 33.51 |
| P/TBV Ratio | 71.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.19, with zero debt.
| Current Ratio | 4.19 |
| Quick Ratio | 4.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,648.55 |
Financial Efficiency
Return on equity (ROE) is -125.17% and return on invested capital (ROIC) is -78.61%.
| Return on Equity (ROE) | -125.17% |
| Return on Assets (ROA) | -70.82% |
| Return on Invested Capital (ROIC) | -78.61% |
| Return on Capital Employed (ROCE) | -163.50% |
| Weighted Average Cost of Capital (WACC) | 6.15% |
| Revenue Per Employee | 271 |
| Profits Per Employee | -9.16M |
| Employee Count | 6 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.38% in the last 52 weeks. The beta is 0.35, so XSAT:HAMLET.B's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +12.38% |
| 50-Day Moving Average | 6.27 |
| 200-Day Moving Average | 6.65 |
| Relative Strength Index (RSI) | 54.86 |
| Average Volume (20 Days) | 164,242 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XSAT:HAMLET.B had revenue of SEK 1,624 and -54.96 million in losses.
| Revenue | 1,624 |
| Gross Profit | 1,624 |
| Operating Income | -55.23M |
| Pretax Income | -54.96M |
| Net Income | -54.96M |
| EBITDA | -44.69M |
| EBIT | -55.23M |
| Earnings Per Share (EPS) | n/a |
Full Income Statement Balance Sheet
The company has 16.41 million in cash and no debt, with a net cash position of 16.41 million or 0.09 per share.
| Cash & Cash Equivalents | 16.41M |
| Total Debt | n/a |
| Net Cash | 16.41M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 33.78M |
| Book Value Per Share | n/a |
| Working Capital | 15.35M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -46.49 million and capital expenditures -353,000, giving a free cash flow of -46.84 million.
| Operating Cash Flow | -46.49M |
| Capital Expenditures | -353,000 |
| Depreciation & Amortization | 10.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -46.84M |
| FCF Per Share | -0.25 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,400,971.31% |
| Pretax Margin | -3,384,540.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XSAT:HAMLET.B does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.86% |
| FCF Yield | -4.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on March 15, 2021. It was a forward split with a ratio of 3.
| Last Split Date | Mar 15, 2021 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |